← FDA Drug Approvals (Drugs@FDA)

VASOCON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVARTIS · Approved 1971-06-07

Drug application

FDA Application #

ANDA080235

Application type

Abbreviated New Drug Application (Generic)

Brand name

VASOCON

Generic name

Naphazoline Hydrochloride

Active ingredients

NAPHAZOLINE HYDROCHLORIDE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1971-06-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown